Affordable cancer drug gets lab test against tough blood cancers
NCT ID NCT04234022
Summary
This study aims to see if a drug called Imuthiol (Zn-DDC), which has been safe in past trials, can kill cancer cells from patients with multiple myeloma or acute leukemia. Researchers will test the drug alone and combined with other medications on cells in a lab, using bone marrow samples donated by 70 patients. The goal is to gather evidence to see if this affordable drug should move into future treatment trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Wolverhampton NHS Trust
RECRUITINGWolverhampton, WV10 0QP, United Kingdom
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.